Fundraising FoxAxogen
NASDAQ: AXGN2 known investors
Find your way into Axogen
Sign up to see every warm intro you have to Axogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves. Its products serve surgeons and healthcare providers treating patients with peripheral nerve damage.
Founders & leadership
MD
Michael DaleDirector, Chief Executive Officer and PresidentPresident, Chief Executive Officer and Board Director at Axogeninc
Investors · 2
Funding
SEC filings, press & company announcements$200M disclosed across 1 round · 2026
- $200MraisedSep 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Axogen do?
- Axogen develops and commercializes technologies for peripheral nerve regeneration and repair, offering clinically proven surgical solutions to restore feeling and function to damaged nerves. Its products serve surgeons and healthcare providers treating patients with peripheral nerve damage.
- Who are Axogen's investors?
- Axogen's investors include ATEL Ventures, Essex Woodlands Healthcare Partners.
- How much funding has Axogen raised?
- Axogen has disclosed $200M raised across 1 round.